Bone Morphogenetic Protein 4 (BMP4) Antibody

Product Graph
299€ (50 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Bone Morphogenetic Protein 4 (BMP4) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx402185
tested applications
ELISA, WB, IF/ICC

Description

Bone Morphogenetic Protein 4 (BMP4) Antibody is a Recombinant Rabbit Monoclonal antibody for the detection of Human BMP4.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Bone Morphogenetic Protein 4 (BMP4)
Host
Rabbit
Reactivity
Human
Recommended Dilution
WB: 1/500 - 1/2000, IF/ICC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
IgG
Expression
Recombinant
Purification
Purified by affinity chromatography.
Size 1
50 µl
Size 2
100 µl
Form
Liquid
Tested Applications
ELISA, WB, IF/ICC
Buffer
PBS, pH 7.4, 150 mM NaCl, 0.02% sodium azide and 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P12644
Background
Antibody anti-BMP4
Status
RUO

Descripción

Related Products

FNab00919

BMP4 antibody

Induces cartilage and bone formation. Also act in mesoderm induction, tooth development, limb formation and fracture repair. Acts in concert with PTHLH/PTHRP to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction(By similarity).

Ver Producto
P4905

Recombinant Mouse BMP4

Ver Producto
abx001316

Bone Morphogenetic Protein 4 (BMP4) Antibody

BMP4 Antibody is a Rabbit Polyclonal antibody against BMP4. The protein encoded by this gene is a member of the bone morphogenetic protein family which is part of the transforming growth factor-beta superfamily. The superfamily includes large families of growth and differentiation factors. Bone morphogenetic proteins were originally identified by an ability of demineralized bone extract to induce endochondral osteogenesis in vivo in an extraskeletal site. This particular family member plays an important role in the onset of endochondral bone formation in humans, and a reduction in expression has been associated with a variety of bone diseases, including the heritable disorder Fibrodysplasia Ossificans Progressiva. Alternative splicing in the 5' untranslated region of this gene has been described and three variants are described, all encoding an identical protein.

Ver Producto